Brean Capital Raises Price Target on NuVasive (NUVA) Following 2Q EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
NuVasive Announces Definitive Settlement With United States
July 28, 2015 4:06 PM EDTSAN DIEGO, CA -- (Marketwired) -- 07/28/15 -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that it has reached a definitive settlement with the U.S. Department of Justice ("DOJ") related to the subpoena issued to the Company by the Office of Inspector General of the Department of Health and Human Services ("OIG") in 2013. NuVasive admits no wrongdoing as part of the settlement.
On April 29, 2015, the Company announced that it had reached an agreement in principle to settle the... More
NuVasive Reports Second Quarter 2015 Financial Results
July 28, 2015 4:05 PM EDTSAN DIEGO, CA -- (Marketwired) -- 07/28/15 -- Second Quarter 2015 Highlights:
Revenue increased 6.4% to $202.9 million, or 8.5% on a constant currency basis;Non-GAAP operating profit margin of 15.3%; GAAP operating profit margin of 12.7%; Adjusted EBITDA margin of 24.9%; Non-GAAP net income of $15.7 million; GAAP net income of $10.3 million;Non-GAAP earnings per share of $0.31; GAAP earnings per share of $0.20;... More